Heterologous stem cell therapy to treat acute liver failure in infants, children and adolescents without the need of immunosuppression
Heterologous stem cell therapy to treat acute liver failure in infants, children and adolescents without the need of immunosuppression
异源干细胞疗法可治疗婴儿、儿童和青少年的急性肝衰竭，无需免疫抑制
批准号：
367713
负责人：
Paganelli Massimiliano
金额：
$5.46万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-05-01 至 2020-05-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute liver failure (ALF) is an extremely severe, progressive syndrome resulting from a sudden insult on the liver exceeding the organ's innate regenerative capacity. ALF in children and adolescents has a poor outcome, with only 50% of patients surviving
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stem cell-derived Encapsulated Liver Tissue to treat liver failure without immunosuppression: technology maturation towards clinical translation
-
批准号：391206
-
项目类别：Operating Grants
-
资助金额：$36.22万
-
财政年份：2018
-
负责人：Paganelli Massimiliano
-
依托单位：
海外基金
